Aptuit Acquires the R&D Center in Verona from GlaxoSmithKline

Advised by Macchi di Cellere Gangemi, Aptuit's purchase of the facility from GlaxoSmithKline has been completed successfully.

GlaxoSmithKline has sold its R&D Center, other properties, and production facilities to Aptuit, a pharmaceutical company of the German group Evotec, to which in 2010 the R&D Center had been granted on loan as part of a complex industrial reorganization that involved the two groups and numerous companies based in USA, UK, Italy and Germany.

Aptuit was assisted by Macchi di Cellere Gangemi partner Simone Rossi, with associates Maria Giulia Sperotto and Roberta Pantaleoni, for the legal aspects.

Aptuit will be able to further expand the facility, update and increase utilities and ensure the future sustainability of research and development activities on site.

Leave A Reply